Prabakaran Desomayanandam

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Squamous Cell Carcinoma

Top Venues

Journal of dietary supplements

Clinical pharmacology : advances and applications

Evidence-based complementary and alternative medicine : eCAM

This page only lists publications with an associated author ORCID identifier.

Publications

Shefali Thanawala, Rajat Shah, R Abiraamasundari, R Senthurselvi, Prabakaran Desomayanandam
Comparative Bioavailability and Benefits on Mental Functions of Novel Extended-Release Caffeine Capsules against Immediate-Release Caffeine Capsules: An Open-Label, Randomized, Cross-over, Single-Dose Two-Way Crossover Study. Journal of dietary supplements (2023)
Shefali Thanawala, Rajat Shah, R Abiraamasundari, R Senthurselvi, Prabakaran Desomayanandam
Comparative Bioavailability and Benefits on Mental Functions of Novel Extended-Release Caffeine Capsules against Immediate-Release Caffeine Capsules: An Open-Label, Randomized, Cross-over, Single-Dose Two-Way Crossover Study. Journal of dietary supplements (2023)
Shefali Thanawala, Rajat Shah, Vasu Karlapudi, Prabakaran Desomayanandam, Arun Bhuvanendran
Efficacy and Safety of TurmXTRA® 60N in Delayed Onset Muscle Soreness in Healthy, Recreationally Active Subjects: A Randomized, Double-Blind, Placebo-Controlled Trial. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Shefali Thanawala, Rajat Shah, Venkateswarlu Somepalli, Venkata Krishnaraju Alluri, Prabakaran Desomayanandam, Arun Bhuvanendran
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Assessing Efficacy and Safety of a Novel Low-Dose Turmeric Extract Formulation in Healthy Adults with Chronic Knee Pain. Clinical pharmacology : advances and applications 13 (2021)